Zucara
2015
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Debt
LATEST DEAL TYPE
$3.9M
LATEST DEAL AMOUNT
5
INVESTORS
Description
Developer of a novel drug therapy designed to prevent hypoglycemia. The company's novel drug therapy helps to restore the body's ability to reduce occurrence of hypoglycemia and its associated acute symptoms and effects, enabling healthcare providers to more aggressively treat their patients with insulin, resulting in better overall health outcomes in the long term.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 1300-661 University Avenue
- Toronto, Ontario M5G 0B7
- Canada
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Zucara’s full profile, request a free trial.
Zucara Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Debt - General | 09-Apr-2018 | $3.9M | 00.000 | Completed | Pre-Clinical Trials | |
| 5. Accelerator/Incubator | 09-Feb-2018 | 00000 | Completed | Pre-Clinical Trials | ||
| 4. Grant | 08-Feb-2018 | 00000 | 00000 | Completed | Pre-Clinical Trials | |
| 3. Grant | 21-Sep-2017 | 00000 | Completed | Pre-Clinical Trials | ||
| 2. Early Stage VC (Series A) | 03-Nov-2016 | Cancelled | Startup | |||
| 1. Early Stage VC | 03-Nov-2016 | $525K | $525K | Completed | Startup |
Zucara Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| JLABS | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| National Research Council Canada | Government | 000 0000 | 000000 0 | |||
| Accel-Rx | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| Centre for Drug Research and Development | Corporation | 000 0000 | 000000 0 | |||
| Toronto Innovation Acceleration Partners | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 |
Zucara Executive Team (5)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Michael Midmer | Chief Executive Officer & Board Member | ||
| Richard Liggins Ph.D | Co-Founder and Chief Scientific Officer | ||
| David Coy Ph.D | Advisor | ||
| Mladen Vranic Ph.D | Advisor |
1 Former Executive
You’re viewing 4 of 5 executives. Get the full list »Zucara Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Claude Piche Ph.D | Self | Board Member | 000 0000 | |
| Jonathon Jafari | Self | Board Member | 000 0000 | |
| Luc Mainville | Self | Chairman | 000 0000 | |
| Michael Midmer | Zucara | Chief Executive Officer & Board Member | 000 0000 | |
| Michael Riddell Ph.D | Self | Chairman of Clinical Advisory Board | 000 0000 |